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The increasing use of cross-sectional imaging has led to
greater detection of incidental lesions in oncology and
non-oncology patients. These incidental lesions are unex-
pected and usually asymptomatic abnormalities that are
identified when imaging for other purposes. These
incidental lesions create a diagnostic and management
challenge for radiologists and clinicians [1]. They may
result in patients having unnecessary investigations and
treatment, which is not without risks or expense. The
American College of Radiologists has developed guidelines
and recommendations for incidentally detected lesions on
abdominal imaging [2]. The guidance developed addresses
incidental findings in the kidney, liver, adrenal glands and
pancreas but does not deal specifically with cancer
patients.
In the case of an incidentally detected renal lesion in a
cancer patient, the incidental abnormality may represent
metastatic disease, a second primary malignancy or a
benign lesion. The diagnosis and management of such
incidental findings will depend in part on the clinical
setting, the pathology and stage of underlying primary
malignancy and the imaging features of the incidental
abnormality [3-6].
In terms of imaging characterisation many incidental
kidney lesions can be fully characterised using ultrasound,
CT or MRI. In characterising a renal mass, in general it is
important to first ensure that the mass is not the result of
non-neoplastic conditions that may mimic a tumour. For
example focal bacterial pyelonephritis, pseudotumours
such as columns of Bertin, hypertrophied tissue adjacent
to scars, vascular anomalies, aneurysms and infarcts.
Further imaging characterisation may suggest that the
lesion is a benign cystic renal tumour, i.e. Bosniak I or II
lesions. If the lesion is solid, unless there are features in
keeping with an angiomyolipoma (AML), it is usually not
possible to differentiate benign from malignant primary
tumour or metastases to the kidney. Therefore either
cystic lesions or solid lesions in which malignancy cannot
be excluded may need further assessment and this is an
indication for a renal biopsy.
Metastases to the kidney are very uncommon. Renal
metastases frequently do not present clinical symptoms
and many patients have no haematuria. Traditionally,
metastases to the kidney are thought to be multiple and
bilateral, however descriptions are limited to case reports.
The most common malignancies metastasing to the
kidney \are lung and breast cancer. Previous imaging or
history is also useful in evaluating metastases to the kidney
as there is often widespread metastatic disease with renal
involvement. Isolated metastasis is very rare and may need
a biopsy in order to distinguish it from primary renal
neoplasm.
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